 | • レポートコード：D005-11551 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、経口抗凝固剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。経口抗凝固剤の種類別市場規模（ワルファリン、ダビガトラン、リバロキサバン、その他）、用途別市場規模（血栓塞栓症、播種性血管内凝固、心臓血管外科、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Akers Biosciences、Novartis AG、AstraZeneca、Pfizer、GlaxoSmithKline、Eisai、Medicure、Eli Lilly、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・経口抗凝固剤の北米市場（アメリカ、カナダ、メキシコ） ・経口抗凝固剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・経口抗凝固剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・経口抗凝固剤の南米市場（ブラジル、アルゼンチン） ・経口抗凝固剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ワルファリン、ダビガトラン、リバロキサバン、その他 ・用途別分析：血栓塞栓症、播種性血管内凝固、心臓血管外科、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Oral Anticoagulant market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oral Anticoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oral Anticoagulant market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oral Anticoagulant market has been segmented into
Warfarin
Dabigatran
Rivaroxaban
Others
By Application, Oral Anticoagulant has been segmented into:
Thromboembolic Disease
Disseminated Intravascular Coagulation
Cardiovascular Surgery
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oral Anticoagulant market presented in the report. This section sheds light on the sales growth of different regional and country-level Oral Anticoagulant markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oral Anticoagulant market.
The report offers in-depth assessment of the growth and other aspects of the Oral Anticoagulant market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Oral Anticoagulant Market Share Analysis
Oral Anticoagulant competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oral Anticoagulant sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oral Anticoagulant sales, revenue and market share for each player covered in this report.
The major players covered in Oral Anticoagulant are:
Akers Biosciences
Novartis AG
AstraZeneca
Pfizer
GlaxoSmithKline
Eisai
Medicure
Eli Lilly
Sanofi
Among other players domestic and global, Oral Anticoagulant market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Anticoagulant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Anticoagulant, with price, sales, revenue and global market share of Oral Anticoagulant in 2018 and 2019.
Chapter 3, the Oral Anticoagulant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anticoagulant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oral Anticoagulant market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oral Anticoagulant sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Oral Anticoagulant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Anticoagulant Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Warfarin
1.2.3 Dabigatran
1.2.4 Rivaroxaban
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Anticoagulant Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Thromboembolic Disease
1.3.3 Disseminated Intravascular Coagulation
1.3.4 Cardiovascular Surgery
1.3.5 Others
1.4 Overview of Global Oral Anticoagulant Market
1.4.1 Global Oral Anticoagulant Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Akers Biosciences
2.1.1 Akers Biosciences Details
2.1.2 Akers Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Akers Biosciences SWOT Analysis
2.1.4 Akers Biosciences Product and Services
2.1.5 Akers Biosciences Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eisai
2.6.1 Eisai Details
2.6.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eisai SWOT Analysis
2.6.4 Eisai Product and Services
2.6.5 Eisai Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Medicure
2.7.1 Medicure Details
2.7.2 Medicure Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Medicure SWOT Analysis
2.7.4 Medicure Product and Services
2.7.5 Medicure Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oral Anticoagulant Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oral Anticoagulant Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Anticoagulant Manufacturer Market Share in 2019
3.3.2 Top 6 Oral Anticoagulant Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oral Anticoagulant Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Anticoagulant Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oral Anticoagulant Revenue and Market Share by Regions (2015-2020)
4.2 North America Oral Anticoagulant Sales and Growth Rate (2015-2020)
4.3 Europe Oral Anticoagulant Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oral Anticoagulant Sales and Growth Rate (2015-2020)
4.5 South America Oral Anticoagulant Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oral Anticoagulant Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oral Anticoagulant Sales, Revenue and Market Share by Country
5.1.1 North America Oral Anticoagulant Sales and Market Share by Country (2015-2020)
5.1.2 North America Oral Anticoagulant Revenue and Market Share by Country (2015-2020)
5.2 United States Oral Anticoagulant Sales and Growth Rate (2015-2020)
5.3 Canada Oral Anticoagulant Sales and Growth Rate (2015-2020)
5.4 Mexico Oral Anticoagulant Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oral Anticoagulant Sales, Revenue and Market Share by Country
6.1.1 Europe Oral Anticoagulant Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oral Anticoagulant Revenue and Market Share by Country (2015-2020)
6.2 Germany Oral Anticoagulant Sales and Growth Rate (2015-2020)
6.3 UK Oral Anticoagulant Sales and Growth Rate (2015-2020)
6.4 France Oral Anticoagulant Sales and Growth Rate (2015-2020)
6.5 Russia Oral Anticoagulant Sales and Growth Rate (2015-2020)
6.6 Italy Oral Anticoagulant Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oral Anticoagulant Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oral Anticoagulant Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oral Anticoagulant Revenue and Market Share by Regions (2015-2020)
7.2 China Oral Anticoagulant Sales and Growth Rate (2015-2020)
7.3 Japan Oral Anticoagulant Sales and Growth Rate (2015-2020)
7.4 Korea Oral Anticoagulant Sales and Growth Rate (2015-2020)
7.5 India Oral Anticoagulant Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oral Anticoagulant Sales and Growth Rate (2015-2020)
7.7 Australia Oral Anticoagulant Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oral Anticoagulant Sales, Revenue and Market Share by Country
8.1.1 South America Oral Anticoagulant Sales and Market Share by Country (2015-2020)
8.1.2 South America Oral Anticoagulant Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oral Anticoagulant Sales and Growth Rate (2015-2020)
8.3 Argentina Oral Anticoagulant Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oral Anticoagulant Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oral Anticoagulant Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oral Anticoagulant Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oral Anticoagulant Sales and Growth Rate (2015-2020)
9.3 Turkey Oral Anticoagulant Sales and Growth Rate (2015-2020)
9.4 Egypt Oral Anticoagulant Sales and Growth Rate (2015-2020)
9.5 South Africa Oral Anticoagulant Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oral Anticoagulant Sales and Market Share by Type (2015-2020)
10.2 Global Oral Anticoagulant Revenue and Market Share by Type (2015-2020)
10.3 Global Oral Anticoagulant Price by Type (2015-2020)
11 Global Oral Anticoagulant Market Segment by Application
11.1 Global Oral Anticoagulant Sales Market Share by Application (2015-2020)
11.2 Global Oral Anticoagulant Revenue Market Share by Application (2015-2020)
11.3 Global Oral Anticoagulant Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oral Anticoagulant Sales, Revenue and Growth Rate (2021-2025)
12.2 Oral Anticoagulant Market Forecast by Regions (2021-2025)
12.2.1 North America Oral Anticoagulant Market Forecast (2021-2025)
12.2.2 Europe Oral Anticoagulant Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oral Anticoagulant Market Forecast (2021-2025)
12.2.4 South America Oral Anticoagulant Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oral Anticoagulant Market Forecast (2021-2025)
12.3 Oral Anticoagulant Market Forecast by Type (2021-2025)
12.3.1 Global Oral Anticoagulant Sales Forecast by Type (2021-2025)
12.3.2 Global Oral Anticoagulant Market Share Forecast by Type (2021-2025)
12.4 Oral Anticoagulant Market Forecast by Application (2021-2025)
12.4.1 Global Oral Anticoagulant Sales Forecast by Application (2021-2025)
12.4.2 Global Oral Anticoagulant Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Oral Anticoagulant Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oral Anticoagulant by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oral Anticoagulant Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Akers Biosciences Basic Information, Manufacturing Base and Competitors
Table 8. Akers Biosciences Oral Anticoagulant Major Business
Table 9. Akers Biosciences Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 10. Akers Biosciences SWOT Analysis
Table 11. Akers Biosciences Oral Anticoagulant Product and Services
Table 12. Akers Biosciences Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Oral Anticoagulant Major Business
Table 15. Novartis AG Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 16. Novartis AG SWOT Analysis
Table 17. Novartis AG Oral Anticoagulant Product and Services
Table 18. Novartis AG Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Oral Anticoagulant Major Business
Table 21. AstraZeneca Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 22. AstraZeneca SWOT Analysis
Table 23. AstraZeneca Oral Anticoagulant Product and Services
Table 24. AstraZeneca Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer Oral Anticoagulant Major Business
Table 27. Pfizer Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 28. Pfizer SWOT Analysis
Table 29. Pfizer Oral Anticoagulant Product and Services
Table 30. Pfizer Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline Oral Anticoagulant Major Business
Table 33. GlaxoSmithKline Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 34. GlaxoSmithKline SWOT Analysis
Table 35. GlaxoSmithKline Oral Anticoagulant Product and Services
Table 36. GlaxoSmithKline Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Eisai Basic Information, Manufacturing Base and Competitors
Table 38. Eisai Oral Anticoagulant Major Business
Table 39. Eisai Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 40. Eisai SWOT Analysis
Table 41. Eisai Oral Anticoagulant Product and Services
Table 42. Eisai Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Medicure Basic Information, Manufacturing Base and Competitors
Table 44. Medicure Oral Anticoagulant Major Business
Table 45. Medicure Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 46. Medicure SWOT Analysis
Table 47. Medicure Oral Anticoagulant Product and Services
Table 48. Medicure Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly Oral Anticoagulant Major Business
Table 51. Eli Lilly Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly Oral Anticoagulant Product and Services
Table 54. Eli Lilly Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sanofi Basic Information, Manufacturing Base and Competitors
Table 56. Sanofi Oral Anticoagulant Major Business
Table 57. Sanofi Oral Anticoagulant Total Revenue (USD Million) (2018-2019)
Table 58. Sanofi SWOT Analysis
Table 59. Sanofi Oral Anticoagulant Product and Services
Table 60. Sanofi Oral Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Oral Anticoagulant Sales by Manufacturer (2018-2019) (K MT)
Table 62. Global Oral Anticoagulant Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Oral Anticoagulant Sales by Regions (2015-2020) (K MT)
Table 64. Global Oral Anticoagulant Sales Market Share by Regions (2015-2020)
Table 65. Global Oral Anticoagulant Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Oral Anticoagulant Sales by Countries (2015-2020) (K MT)
Table 67. North America Oral Anticoagulant Sales Market Share by Countries (2015-2020)
Table 68. North America Oral Anticoagulant Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Oral Anticoagulant Revenue Market Share by Countries (2015-2020)
Table 70. Europe Oral Anticoagulant Sales by Countries (2015-2020) (K MT)
Table 71. Europe Oral Anticoagulant Sales Market Share by Countries (2015-2020)
Table 72. Europe Oral Anticoagulant Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Oral Anticoagulant Sales by Regions (2015-2020) (K MT)
Table 74. Asia-Pacific Oral Anticoagulant Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Oral Anticoagulant Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Oral Anticoagulant Sales by Countries (2015-2020) (K MT)
Table 77. South America Oral Anticoagulant Sales Market Share by Countries (2015-2020)
Table 78. South America Oral Anticoagulant Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Oral Anticoagulant Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Oral Anticoagulant Sales by Countries (2015-2020) (K MT)
Table 81. Middle East & Africa Oral Anticoagulant Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Oral Anticoagulant Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Oral Anticoagulant Revenue Market Share by Countries (2015-2020)
Table 84. Global Oral Anticoagulant Sales by Type (2015-2020) (K MT)
Table 85. Global Oral Anticoagulant Sales Share by Type (2015-2020)
Table 86. Global Oral Anticoagulant Revenue by Type (2015-2020) (USD Million)
Table 87. Global Oral Anticoagulant Revenue Share by Type (2015-2020)
Table 88. Global Oral Anticoagulant Sales by Application (2015-2020) (K MT)
Table 89. Global Oral Anticoagulant Sales Share by Application (2015-2020)
Table 90. Global Oral Anticoagulant Sales Forecast by Regions (2021-2025) (K MT)
Table 91. Global Oral Anticoagulant Market Share Forecast by Regions (2021-2025)
Table 92. Global Oral Anticoagulant Sales Forecast by Type (2021-2025) (K MT)
Table 93. Global Oral Anticoagulant Market Share Forecast by Type (2021-2025)
Table 94. Global Oral Anticoagulant Sales Forecast by Application (2021-2025)
Table 95. Global Oral Anticoagulant Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oral Anticoagulant Picture
Figure 2. Global Sales Market Share of Oral Anticoagulant by Type in 2019
Figure 3. Warfarin Picture
Figure 4. Dabigatran Picture
Figure 5. Rivaroxaban Picture
Figure 6. Others Picture
Figure 7. Oral Anticoagulant Sales Market Share by Application in 2018
Figure 8. Thromboembolic Disease Picture
Figure 9. Disseminated Intravascular Coagulation Picture
Figure 10. Cardiovascular Surgery Picture
Figure 11. Others Picture
Figure 12. Global Oral Anticoagulant Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Oral Anticoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Oral Anticoagulant Sales Market Share by Manufacturer in 2019
Figure 33. Global Oral Anticoagulant Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Oral Anticoagulant Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Oral Anticoagulant Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Oral Anticoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Oral Anticoagulant Revenue Market Share by Regions (2015-2020)
Figure 40. Global Oral Anticoagulant Revenue Market Share by Regions in 2018
Figure 41. North America Oral Anticoagulant Sales and Growth Rate (2015-2020)
Figure 42. Europe Oral Anticoagulant Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Oral Anticoagulant Sales and Growth Rate (2015-2020)
Figure 44. South America Oral Anticoagulant Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Oral Anticoagulant Sales and Growth Rate (2015-2020)
Figure 46. North America Oral Anticoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Oral Anticoagulant Sales Market Share by Countries (2015-2020)
Figure 48. North America Oral Anticoagulant Sales Market Share by Countries in 2018
Figure 49. North America Oral Anticoagulant Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Oral Anticoagulant Revenue Market Share by Countries in 2018
Figure 51. United States Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Oral Anticoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Oral Anticoagulant Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Oral Anticoagulant Revenue Market Share by Countries in 2019
Figure 57. Germany Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Oral Anticoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Oral Anticoagulant Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Oral Anticoagulant Revenue Market Share by Regions 2019
Figure 65. China Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Oral Anticoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Oral Anticoagulant Sales Market Share by Countries in 2019
Figure 72. South America Oral Anticoagulant Revenue Market Share by Countries in 2019
Figure 73. Brazil Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Oral Anticoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Oral Anticoagulant Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Oral Anticoagulant Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Oral Anticoagulant Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Oral Anticoagulant Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Oral Anticoagulant Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Oral Anticoagulant Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Oral Anticoagulant Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Oral Anticoagulant Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Oral Anticoagulant Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Oral Anticoagulant Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Oral Anticoagulant Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
ペプチド及び抗凝固薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peptide and Anticoagulant Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 652.8 million by 2025, from USD 477.3 million in 2019. The Peptid…- 経口セファロスポリンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Cephalosporin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Cephalosporin market …
- 経口気管内チューブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Endotracheal Tube market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Endotracheal Tube…
- 経口X線装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral X-Ray Machines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral X-Ray Machines marke…
- 犬用経口咀嚼錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Canine Oral Chewable Tablets market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canine Oral Chew…